PlasmaTech Biopharma (PTBI) Posts Markedly Better Q1 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Tech selloff weighs down Wall Street as bond yields climb
- Francisco Partners to acquire Weave Communications for $650M
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Goldman Sachs to acquire real estate company LCN for up to $410M
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
PlasmaTech Biopharmaceuticals (PTBI) Files 1.93M Common Shelf for Shareholders
May 15, 2015 6:11 AM EDTPlasmaTech Biopharmaceuticals (NASDAQ: PTBI) filed a registration with the U.S. SEC to sell up to 1,925,000 Shares of Common Stock on behalf of Selling Shareholders.
... More